RxDoctor Payments DataLook up a doctor →

Mehul Nagarsheth, MD

Glaucoma Specialist · Wyomissing, PANPI 1073774774

Payments from drug & device makers

$31,728in general payments, 2019–2025

Across 450 payments — averaging $70.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$20K
  • AbbVie$4K
  • Sight Sciences, Inc.$2K
  • Alcon$2K
  • NEW World Medical,inc.$1K
  • Nova Eye, Inc.$1K
  • plus $2K from 18 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few glaucoma specialist providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$793,352
Medicare patients
1,166
Services billed
6,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other glaucoma specialist in Wyomissing

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →